• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部腺样囊性癌

Adenoid cystic carcinoma of the head and neck.

作者信息

Jones A S, Hamilton J W, Rowley H, Husband D, Helliwell T R

机构信息

Department of Otolaryngology, University of Liverpool, UK.

出版信息

Clin Otolaryngol Allied Sci. 1997 Oct;22(5):434-43. doi: 10.1046/j.1365-2273.1997.00041.x.

DOI:10.1046/j.1365-2273.1997.00041.x
PMID:9372255
Abstract

Adenoid cystic carcinoma has a long natural history but frequently proves fatal. The present study describes 108 patients with an adenoid cystic carcinoma of the head and neck seen over a 30-year period. Analysis of the data utilized both univariate and multivariate methods. Forty per cent of patients had tumours arising from the oral cavity and half of these were in the hard palate; 29% occurred in the major salivary glands; 41% of tumours were locally advanced at presentation and 11% had lymph node metastases at this time. The histological pattern was solid in 25%, cribriform in 40% and tubular in 20%. In addition, 15% of patients had a polymorphous low-grade adenocarcinoma and these were analysed separately. Primary site recurrence was more common in the presence of locally advanced tumours at presentation (T3-4) (P = 0.0093). Only six patients had surgery with adjuvant radiotherapy. Six patients had no curative treatment, 21 had primary radiotherapy, 39 had local excision and 42 radical excision. The actuarial primary site recurrence rate was 100% at 30 years. The neck node recurrence rate was 23% at 15 years. Tumour specific survival was 40% at 20 years. Solid histology had a worse prognosis than other histological types (P = 0.0429) but those patients with polymorphous low-grade adenocarcinomas fared very well. Patients with tumours of the hard palate fared better than those patients with tumours at other sites (P = 0.0301). Early disease at the primary site (T1-2) was a good prognostic sign (P = 0.0013). Patients with neck node metastases at presentation tended to do badly (P = 0.009).

摘要

腺样囊性癌自然病程较长,但往往会导致死亡。本研究描述了30年间诊治的108例头颈部腺样囊性癌患者。数据分析采用单变量和多变量方法。40%的患者肿瘤起源于口腔,其中一半位于硬腭;29%发生于大唾液腺;41%的肿瘤初诊时为局部晚期,此时11%已有淋巴结转移。组织学类型中,实性型占25%,筛状型占40%,管状型占20%。此外,15%的患者为多形性低度腺癌,对其进行单独分析。初诊时存在局部晚期肿瘤(T3 - 4)时,原发部位复发更为常见(P = 0.0093)。仅6例患者接受了手术加辅助放疗。6例患者未接受根治性治疗,21例接受了原发灶放疗,39例接受了局部切除,42例接受了根治性切除。30年时原发部位的精算复发率为100%。15年时颈部淋巴结复发率为23%。20年时肿瘤特异性生存率为40%。实性组织学类型的预后比其他组织学类型差(P = 0.0429),但多形性低度腺癌患者预后良好。硬腭肿瘤患者的预后优于其他部位肿瘤患者(P = 0.0301)。原发部位早期病变(T1 - 2)是良好的预后指标(P = 0.0013)。初诊时伴有颈部淋巴结转移的患者预后往往较差(P = 0.009)。

相似文献

1
Adenoid cystic carcinoma of the head and neck.头颈部腺样囊性癌
Clin Otolaryngol Allied Sci. 1997 Oct;22(5):434-43. doi: 10.1046/j.1365-2273.1997.00041.x.
2
Head and neck adenoid cystic carcinoma: A prospective multicenter REFCOR study of 95 cases.头颈部腺样囊性癌:一项对95例患者的前瞻性多中心REFCOR研究。
Eur Ann Otorhinolaryngol Head Neck Dis. 2016 Feb;133(1):13-7. doi: 10.1016/j.anorl.2015.09.009. Epub 2015 Oct 20.
3
[Adenoid cystic carcinoma of the head and neck: a retrospective series of 169 cases].[头颈部腺样囊性癌:169例回顾性研究系列]
Cancer Radiother. 2012 Jul-Aug;16(4):247-56. doi: 10.1016/j.canrad.2012.02.003. Epub 2012 May 29.
4
Neutron radiotherapy for adenoid cystic carcinoma of minor salivary glands.小唾液腺腺样囊性癌的中子放射治疗
Int J Radiat Oncol Biol Phys. 1996 Aug 1;36(1):87-93. doi: 10.1016/s0360-3016(96)00213-1.
5
Treatment of locally advanced adenoid cystic carcinoma of the head and neck with neutron radiotherapy.头颈部局部晚期腺样囊性癌的中子放射治疗
Int J Radiat Oncol Biol Phys. 2000 Feb 1;46(3):551-7. doi: 10.1016/s0360-3016(99)00445-9.
6
[Adenoid cystic carcinoma of the head and neck: a review of 30 cases].[头颈部腺样囊性癌:30例病例回顾]
Rev Laryngol Otol Rhinol (Bord). 2003;124(4):235-41.
7
Adenoid cystic carcinoma of the head and neck. Controllable and uncontrollable factors in treatment and prognosis.头颈部腺样囊性癌。治疗与预后中的可控和不可控因素。
ORL J Otorhinolaryngol Relat Spec. 1980;42(6):346-367. doi: 10.1159/000275515.
8
Clinical outcomes of adenoid cystic carcinoma of the head and neck: a single institution 20-year experience.头颈部腺样囊性癌的临床结局:单机构20年经验
J Laryngol Otol. 2016 Jul;130(7):680-5. doi: 10.1017/S0022215116008124. Epub 2016 Jun 8.
9
Adenoid cystic carcinoma of the head and neck.头颈部腺样囊性癌
Arch Otolaryngol Head Neck Surg. 1994 Jul;120(7):721-6. doi: 10.1001/archotol.1994.01880310027006.
10
Tumours of the minor salivary glands.
Clin Otolaryngol Allied Sci. 1998 Feb;23(1):27-33. doi: 10.1046/j.1365-2273.1998.00088.x.

引用本文的文献

1
Distinct patterns of osteoradionecrosis after photon-based radiotherapy and carbon ion radiotherapy for unresectable adenoid cystic carcinoma of the head and neck: case series from two institutions.基于光子的放射治疗和碳离子放射治疗后不可切除的头颈部腺样囊性癌的骨放射性坏死的不同模式:来自两个机构的病例系列
Acta Oncol. 2025 Jan 15;64:63-68. doi: 10.2340/1651-226X.2025.42209.
2
Recurrence after primary salivary gland carcinoma: Frequency, survival, and risk factors.原发性唾液腺癌复发:发生率、生存率及危险因素
Head Neck. 2025 Jan;47(1):47-56. doi: 10.1002/hed.27880. Epub 2024 Jul 27.
3
A Novel Scoring System for MYB RNA In Situ Hybridization Displays High Sensitivity and Specificity for Adenoid Cystic Carcinoma in a Clinical Setting.
一种用于 MYB RNA 原位杂交的新型评分系统在临床环境中对腺样囊性癌具有高灵敏度和特异性。
Head Neck Pathol. 2024 Jun 19;18(1):51. doi: 10.1007/s12105-024-01656-z.
4
Clinical outcome and prognostic factors in adenoid cystic carcinoma of the external auditory canal: proposal for a refined T-stage classification system.临床结局和外耳道腺样囊性癌的预后因素:提出改良的 T 分期分类系统。
Eur Arch Otorhinolaryngol. 2023 Aug;280(8):3625-3633. doi: 10.1007/s00405-023-07876-3. Epub 2023 Feb 13.
5
Adenoid cystic carcinoma of the parotid gland.腮腺腺样囊性癌
Radiol Case Rep. 2023 Jan 6;18(3):1069-1072. doi: 10.1016/j.radcr.2022.12.047. eCollection 2023 Mar.
6
Role of postoperative radiotherapy in resected adenoid cystic carcinoma of the head and neck.术后放疗在头颈部腺样囊性癌切除术后的作用。
Radiat Oncol. 2022 Dec 1;17(1):197. doi: 10.1186/s13014-022-02165-5.
7
A Contemporary Review of Molecular Therapeutic Targets for Adenoid Cystic Carcinoma.腺样囊性癌分子治疗靶点的当代综述
Cancers (Basel). 2022 Feb 16;14(4):992. doi: 10.3390/cancers14040992.
8
Long-Term Outcomes of Personalized Stereotactic Ablative Brachytherapy for Recurrent Head and Neck Adenoid Cystic Carcinoma after Surgery or External Beam Radiotherapy: A 9-Year Study.个性化立体定向消融近距离放射治疗手术或外照射放疗后复发性头颈部腺样囊性癌的长期疗效:一项9年研究。
J Pers Med. 2021 Aug 26;11(9):839. doi: 10.3390/jpm11090839.
9
Quantitative ubiquitylomics reveals the ubiquitination regulation landscape in oral adenoid cystic carcinoma.定量泛素组学揭示口腔腺样囊性癌中的泛素化调控图谱。
Biosci Rep. 2021 Aug 27;41(8). doi: 10.1042/BSR20211532.
10
Tumor growth rate as a prognostic factor for metastatic or recurrent adenoid cystic carcinoma of the head and neck patients treated with carboplatin plus paclitaxel.肿瘤生长率作为卡铂联合紫杉醇治疗头颈部腺样囊性癌转移或复发患者的预后因素。
Eur Arch Otorhinolaryngol. 2021 Aug;278(8):3037-3043. doi: 10.1007/s00405-020-06481-y. Epub 2020 Nov 21.